← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #267 OF 1,000 MOST-CITED

Written records kept in individual logs

FDA cited this observation 83 times across 83 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs83
BY FISCAL YEAR
FY202510
FY20249
FY20238
FY20228
FY20212
FY20208
FY201913
FY201814
FY201711

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.5× the rate of the average FDA-cited firm (37.4% vs 8.3%), across 83 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Written records of major equipment cleaning, maintenance and use are not included in individual equipment logs.

EUROSIREL S.P.A · Cusago · Drugs · 2025-09-26

Written records of major equipment use are not included in individual equipment logs.

Eurofins BioPharma Product Testing ENCO, LLC. · Jacksonville, Florida · Drugs · 2025-09-25

Written records of major equipment cleaning, maintenance and use are not included in individual equipment logs.

Fareva Morton Grove, Inc. · Morton Grove, Illinois · Drugs · 2025-08-12

Written records of major equipment cleaning and use are not included in individual equipment logs.

DOH Central Pharmacy · Tallahassee, Florida · Drugs · 2025-07-28

Written records of major equipment cleaning and use are not included in individual equipment logs.

Dhaliwal Labs South LLC · Dallas, Texas · Drugs · 2025-06-26

Written records of major equipment cleaning, maintenance and use are not included in individual equipment logs.

Creative Essences Inc · Santa Fe Springs, California · Drugs · 2025-03-25

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →